Opko Health, Inc.
- Country
- 🇨🇱Chile
- Ownership
- Public
- Established
- 2005-01-01
- Employees
- 3.9K
- Market Cap
- -
- Website
- http://www.opko.com
Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism
- Conditions
- Interventions
- First Posted Date
- 2022-09-16
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- OPKO Health, Inc.
- Target Recruit Count
- 2
- Registration Number
- NCT05543928
- Locations
- 🇺🇸
Nationwide Childrens Hospital, Columbus, Ohio, United States
Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19
- Conditions
- Interventions
- First Posted Date
- 2020-09-16
- Last Posted Date
- 2024-05-28
- Lead Sponsor
- OPKO Health, Inc.
- Target Recruit Count
- 171
- Registration Number
- NCT04551911
- Locations
- 🇺🇸
OPKO Investigative Site, Omaha, Nebraska, United States
4Kscore Using Serum Stored Uncentrifuged
- Conditions
- First Posted Date
- 2019-10-17
- Last Posted Date
- 2019-10-17
- Lead Sponsor
- OPKO Health, Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT04130776
- Locations
- 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Quality of Life and Visual Acuity of Visglyc Eye Drops on Dry Eye Patients
- Conditions
- Interventions
- First Posted Date
- 2019-08-21
- Last Posted Date
- 2021-03-23
- Lead Sponsor
- OPKO Health, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT04063644
- Locations
- 🇪🇸
Hospital Universitario 12 de Octubre, Madrid, Spain
Safety and Efficacy Study of MOD-4023 to Treat Children With Growth Hormone Deficiency
- First Posted Date
- 2019-03-14
- Last Posted Date
- 2021-08-12
- Lead Sponsor
- OPKO Health, Inc.
- Target Recruit Count
- 44
- Registration Number
- NCT03874013
- Locations
- 🇯🇵
Fukuyama City Hospital, Fukuyama, Hiroshima, Japan
🇯🇵Hospital of the University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan
🇯🇵National Hospital Organization Kure Medical Center & Chugoku Cancer Center, Kure, Hiroshima, Japan
A Clinical Study Investigating the Comparability of Somatrogon in Two Different Drug Product Presentations
- First Posted Date
- 2019-01-22
- Last Posted Date
- 2020-04-28
- Lead Sponsor
- OPKO Health, Inc.
- Target Recruit Count
- 49
- Registration Number
- NCT03810664
- Locations
- 🇺🇸
QPS Miami Research Associates, Miami, Florida, United States
Efficacy and Safety of a Intra-articular Injection, ENKO1, in Patients With Symptomatic Knee Osteoarthritis.
- First Posted Date
- 2018-12-03
- Last Posted Date
- 2021-03-23
- Lead Sponsor
- OPKO Health, Inc.
- Target Recruit Count
- 175
- Registration Number
- NCT03762408
- Locations
- 🇪🇸
Clínica ISMEC, Sevilla, Spain
🇪🇸Consell calatà de l'Esport, Esplugues De Llobregat, Barcelona, Spain
🇪🇸Clínica Novo Sancti Petri, Chiclana de la Frontera, Cádiz, Spain
Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy Subjects
- Conditions
- Interventions
- First Posted Date
- 2018-09-07
- Last Posted Date
- 2019-09-30
- Lead Sponsor
- OPKO Health, Inc.
- Target Recruit Count
- 67
- Registration Number
- NCT03660800
- Locations
- 🇺🇸
WCCT Global, Inc., Cypress, California, United States
Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2022-05-11
- Lead Sponsor
- OPKO Health, Inc.
- Target Recruit Count
- 256
- Registration Number
- NCT03602261
- Locations
- 🇺🇸
Research by Design, LLC, Chicago, Illinois, United States
🇺🇸Northshore University Health, Evanston, Illinois, United States
🇺🇸Southwest Houston Research LTD, Houston, Texas, United States
Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency
- First Posted Date
- 2018-07-17
- Last Posted Date
- 2022-12-09
- Lead Sponsor
- OPKO Health, Inc.
- Target Recruit Count
- 69
- Registration Number
- NCT03588884
- Locations
- 🇺🇸
Research by Design, LLC, Chicago, Illinois, United States
🇺🇸National Institute of Clinical Research, Inc., Garden Grove, California, United States
🇺🇸Spaulding Clinical Research, West Bend, Wisconsin, United States